Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The Company’s comprehensive bio simulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. It operates through two segments: software and services. It offers software products for pharmaceutical research, development, and commercialization, including GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym and others. In addition, it also delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development.


NDAQ:SLP - Post by User

Simulations Plus Inc
<< Previous
 Bullboard Posts
User Avatar Image
(306)
•••
Post by whytestockson Jan 22, 2025 3:15pm
13 Views
Post# 36415686

Simulations Plus and Enabling Technologies Consortium Announ

Simulations Plus and Enabling Technologies Consortium Announ
NEWS: $SLP Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus&#xAE; EnhancementsIndustry partners to provide funding and data to support ACAT&#x2122; model improvements Simulations Plus, Inc. (Nasdaq: SLP) (&#x201C;Simulations Plus&#x201D;), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communication...SLP - Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus&#xAE; Enhancements

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities